Gender Disparities in Alcohol Use Disorder Treatment Among Privately Insured Patients with Alcohol-Associated Cirrhosis

被引:74
作者
Mellinger, Jessica L. [1 ]
Fernandez, Anne [2 ]
Shedden, Kerby [3 ]
Winder, G. Scott [2 ]
Fontana, Robert J. [1 ]
Volk, Michael L. [4 ]
Blow, Frederic C. [2 ,5 ]
Lok, Anna S. F. [1 ]
机构
[1] Univ Michigan, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA
[4] Loma Linda Univ Hlth, Inst Transplantat, Loma Linda, CA USA
[5] VA Ctr Clin Management Res, Ann Arbor, MI USA
关键词
Alcoholic Cirrhosis; Utilization; Substance Use Treatment; Female; NATIONAL EPIDEMIOLOGIC SURVEY; LIVER-DISEASE; RISK DRINKING; SUBSTANCE USE; DEPENDENCE; PREVALENCE; HEPATITIS; TRENDS; IDENTIFICATION; TOPIRAMATE;
D O I
10.1111/acer.13944
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background The burden of alcohol-associated cirrhosis (AC) is high, and though alcohol cessation improves mortality, many patients fail to engage in alcohol use disorder (AUD) treatment and continue drinking. Our aim was to determine rates, predictors, and outcomes of AUD treatment utilization in AC patients with private insurance. Methods We collected data from persons with AC (diagnosed by ICD-9/ICD-10 codes), aged 18 to 64 years, enrolled in the Truven MarketScan Commercial Claims and Encounters database (2009 to 2016). We determined rates and predictors of substance abuse treatment visits as well as rates of alcohol relapse prevention medication prescriptions, weighted to the national employer-sponsored insured population. Effects of AUD treatment utilization on decompensation rates were calculated using proportional hazards regression with propensity score adjustment. Results A total of 66,053 AC patients were identified, 32% were female, and mean age at diagnosis was 54.5 years. About 72% had insurance coverage for substance abuse treatment. Overall, AUD treatment utilization rates were low, with only 10% receiving a face-to-face mental health or substance abuse visit and only 0.8% receiving a Food and Drug Administration (FDA)-approved relapse prevention medication within 1 year of index diagnosis. Women were less likely to receive a face-to-face visit (hazard ratio [HR] 0.84, p < 0.001) or an FDA-approved relapse prevention medication (0.89, p = 0.05) than men. AC patients who had a clinic visit for AUD treatment or used FDA-approved relapse medication showed decreased risk of decompensation at 1 year (HR 0.85, p < 0.001 for either). Conclusions AUD treatment utilization is associated with lower decompensation rates among privately insured patients with AC. Women were less likely to utilize AUD treatment visits. Efforts to reduce gender-specific barriers to treatment are urgently needed to improve outcomes.
引用
收藏
页码:334 / 341
页数:8
相关论文
共 40 条
  • [11] Substance abuse treatment entry, retention, and outcome in women: A review of the literature
    Greenfield, Shelly F.
    Brooks, Audrey J.
    Gordon, Susan M.
    Green, Carla A.
    Kropp, Frankie
    McHugh, R. Kathryn
    Lincoln, Melissa
    Hien, Denise
    Miele, Gloria M.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2007, 86 (01) : 1 - 21
  • [12] Clinical Impact of Alcohol-Related Cirrhosis in the Next Decade: Estimates Based on Current Epidemiological Trends in the United States
    Guirguis, John
    Chhatwal, Jagpreet
    Dasarathy, Jaividhya
    Rivas, John
    McMichael, David
    Nagy, Laura E.
    McCullough, Arthur J.
    Dasarathy, Srinivasan
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2015, 39 (11) : 2085 - 2094
  • [13] The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings
    Hasin, Deborah S.
    Grant, Bridget F.
    [J]. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2015, 50 (11) : 1609 - 1640
  • [14] Oral topiramate for treatment of alcohol dependence: a randomised controlled trial
    Johnson, BA
    Ait-Daoud, N
    Bowden, CL
    DiClemente, CC
    Roache, JD
    Lawson, K
    Javors, MA
    Ma, JZ
    [J]. LANCET, 2003, 361 (9370) : 1677 - 1685
  • [15] Topiramate for treating alcohol dependence - A randomized controlled trial
    Johnson, Bankole A.
    Rosenthal, Norman
    Capece, Julie A.
    Wiegand, Frank
    Mao, Lian
    Beyers, Karen
    McKay, Amy
    Ait-Daoud, Nassima
    Anton, Raymond F.
    Ciraulo, Domenic A.
    Kranzler, Henry R.
    Mann, Karl
    O'Malley, Stephanie S.
    Swift, Robert M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (14): : 1641 - 1651
  • [16] Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings A Systematic Review and Meta-analysis
    Jonas, Daniel E.
    Amick, Halle R.
    Feltner, Cynthia
    Bobashev, Georgiy
    Thomas, Kathleen
    Wines, Roberta
    Kim, Mimi M.
    Shanahan, Ellen
    Gass, C. Elizabeth
    Rowe, Cassandra J.
    Garbutt, James C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (18): : 1889 - 1900
  • [17] Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review
    Khan, Anam
    Tansel, Aylin
    White, Donna L.
    Kayani, Waleed Tallat
    Bano, Shah
    Lindsay, Jan
    El-Serag, Hashem B.
    Kanwal, Fasiha
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (02) : 191 - +
  • [18] Gender Differences in Lifetime Alcohol Dependence: Results from the National Epidemiologic Survey on Alcohol and Related Conditions
    Khan, Sharaf
    Okuda, Mayumi
    Hasin, Deborah S.
    Secades-Villa, Roberto
    Keyes, Katherine
    Lin, Keng-Han
    Grant, Bridget
    Blanco, Carlos
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2013, 37 (10) : 1696 - 1705
  • [19] Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
    Klimas, Jan
    Tobin, Helen
    Field, Catherine-Anne
    O'Gorman, Clodagh S. M.
    Glynn, Liam G.
    Keenan, Eamon
    Saunders, Jean
    Bury, Gerard
    Dunne, Colum
    Cullen, Walter
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (12):
  • [20] The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases
    Kramer, J. R.
    Davila, J. A.
    Miller, E. D.
    Richardson, P.
    Giordano, T. P.
    El-Serag, H. B.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (03) : 274 - 282